Jury Sides With Pitt In $37M Radiation Patent Row With Varian
A Pennsylvania federal jury on Wednesday upheld a patent for a cancer-treatment device owned by the University of Pittsburgh, leaving Varian Medical Systems Inc. facing $37 million in potential damages as...To view the full article, register now.
Already a subscriber? Click here to view full article